SCHEMBL6877330

SCHEMBL6877330

O=C(O)CCNCCC1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 3/20 0.47
PHF8 Q9UPP1 3/20 0.47
KDM2A Q9Y2K7 3/20 0.47
KDM4C Q9H3R0 2/20 0.47
KDM4A O75164 1/20 0.47
EPHX1 P07099 3/20 0.47
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.44
ALDH1A1 P00352 1/20 0.43
EPHX2 P34913 2/20 0.41
KMT2A Q03164 1/20 0.40
ITGB3 P05106 4/20 0.40
ITGA2B P08514 4/20 0.40
F2R P25116 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1677750 0.98 KDM5A (0.46) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL10389346 0.87 EPHX1 (0.46) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL4171328 0.86 EPHX1 (0.49) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL3197213 0.84 ITGB3 (0.48) KDM5APHF8KDM2AKDM4CKDM4A
Hydrochloric Acid SCHEMBL1677522 0.81 EPHX1 (0.45) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL716430 0.81 SIGMAR1 (0.48) EPHX1HPGDKMT2A
SCHEMBL7716618 0.80 PLG (0.44) KDM5APHF8KDM2AKDM4CLMNA
SCHEMBL27617747 0.80 EPHX2 (0.51) EPHX1HPGDALDH1A1EPHX2KMT2A
SCHEMBL31688784 0.80 EPHX1 (0.42) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL1595661 0.79 HPGD (0.55) KDM5APHF8KDM2AKDM4CKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100522150-C Angiogenesis inhibitor SANTEN PHARMACEUTICAL CO LTD (JP) 2009-08-05 CN disclosed
CN-1324012-C TNF-alpha prodn. inhibitors SANTEN PHARMACEUTICAL CO LTD (JP) 2007-07-04 CN disclosed
CN-1307159-C TNF-alpha prodn. inhibitors SANTEN PHARMACEUTICAL CO LTD (JP) 2007-03-28 CN disclosed
CN-1284771-C TNF-alpha production inhibitors SANTEN PHARMACEUTICAL CO LTD (JP) 2006-11-15 CN disclosed
CN-1604774-A Angiogenesis inhibitor SANTEN PHARMACEUTICAL CO LTD (JP) 2005-04-06 CN disclosed
CN-1590375-A TNF-alpha prodn. inhibitors SANTEN PHARMACEUTICAL CO LTD (JP) 2005-03-09 CN disclosed
CN-1590374-A TNF-alpha prodn. inhibitors SANTEN PHARMACEUTICAL CO LTD (JP) 2005-03-09 CN disclosed
EP-1457205-A1 ANGIOGENESIS INHIBITOR SANTEN PHARMACEUTICAL CO., LTD. (JP) 2004-09-15 EP disclosed
CN-1432000-A TNF-alpha production inhibitors SANTEN PHARMACEUTICAL CO LTD (JP) 2003-07-23 CN disclosed